Last edition
News about Global Pharma
Strides Gets USFDA Approval for Icosapent Ethyl Capsules
The product complements Strides' range of approved soft gelatin capsules.
Global Pharma | 09/10/2023 | By Manvi | 639
This product is bioequivalent to the reference listed drug (RLD), Nexium 24 HR DelayedRelease Capsules, 2.0mg (OTC), of AstraZeneca Pharmaceuticals LP.
Global Pharma | 09/10/2023 | By Manvi | 622
Sun Pharma to Acquire 38% Stake in EzeRx Health Tech for Rs 29 Crore
Sun Pharma will acquire a 37.76% equity shareholding in EzeRx at a cost of Rs 28.69 crore, according to a stock exchange filing.
Global Pharma | 09/10/2023 | By Manvi | 943
REFCOLD India 2023 Sets to Showcase India's Prowess in Refrigeration and Cold Chain Industry Map
The collaboration encompasses the presentation of cutting-edge technological solutions, forging new partnerships and unlocking business opportunities.
Global Pharma | 09/10/2023 | By Manvi | 415
Granules India's Losartan and Hydrochlorothiazide Tablets Gets US FDA Approval
These approved tablets are deemed bioequivalent and therapeutically equivalent to the reference listed drug (RLD), Hyzaar Tablets, marketed by Organon LLC.
Global Pharma | 03/10/2023 | By Manvi | 1089
Lupin Acquires Five Brands from Menarini
The brands are Piclin (Picosulphate Sodium), Menoctyl (Otilonium Bromide), Sucramal O (Sucralfate + Oxetacaine), Pyridium (Phenazopyridine) and Distaclor (Cefaclor).
Global Pharma | 26/09/2023 | By Manvi | 1013
Croatian Pharma Producer JGL Completes 53 Million Euro Investment Project
The project, named INTEGRA, included construction of high-tech facilities on two locations near Rijeka, and took three years to complete, the company said.
Global Pharma | 26/09/2023 | By Manvi | 1035
Aurobindo Pharma Signs MoU With GITAM
Aurobindo Pharma Limited entered a memorandum of understanding (MoU) with GITAM to train its employees from the Vizag cluster. As a part of the MoU, the institution will offer a custom designed management development programme (MDP) ‘Auro Astra’ to Aurobindo Pharma employees.
Global Pharma | 26/09/2023 | By Manvi | 1134
Quadria Capital-Backed Akums Kicks Off 2024 IPO Plans
Delhi-based Akums Drugs and Pharmaceuticals Ltd has picked four investment banks as advisors and kicked off the process to prepare for a listing in 2024.
Global Pharma | 26/09/2023 | By Manvi | 1538
Mankind Pharma Partners with SpiceJet, Elevating Brand Awareness through Plane Displays
Mankind Pharma has taken a pioneering step by introducing 120 DMF quality API medicines in the Indian market, which conform to stringent international standards.
Global Pharma | 22/09/2023 | By Manvi | 814
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy